SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-221544
Filing Date
2023-08-25
Accepted
2023-08-25 16:31:00
Documents
12
Period of Report
2023-08-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d540429d8k.htm   iXBRL 8-K 40059
  Complete submission text file 0001193125-23-221544.txt   166495

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230822.xsd EX-101.SCH 2872
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230822_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230822_pre.xml EX-101.PRE 11725
6 EXTRACTED XBRL INSTANCE DOCUMENT d540429d8k_htm.xml XML 3526
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 231208807
SIC: 2834 Pharmaceutical Preparations